Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2016-002214-47Phase 3Completed
Phase 3, randomised trial in hypertension (HTN) comparing Amlodipine + celecoxib with Amlodipine + matched celecoxib placebo (2 arms). Primary endpoint: Change in mean daytime ambulatory systolic blood pressure. Started Aug 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2016-002214-47.